ASDMITA-RCTNCT07326423
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With Autism
A study testing Mental Imagery Therapy for Autism (MITA) and General executive function in people with ASD, run by ImagiRation, LLC at 1 site in Brazil.
Trial summary
Mental Imagery Therapy for Autism (MITA) is a highly innovative adaptive language therapy application for children with autism. MITA exercises are limitless in variations, therefore avoiding routinization. Each activity is dynamic, quickly adjusting to the child's exact ability level. Read more about this study
- Who is it for?
- Ages 2 to 5 years
- Conditions the study is for
- ASD
- What is being tested?
- Mental Imagery Therapy for Autism (MITA) and General executive function
- Type of treatment
- Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteBrazil
- Study dates
- 1 Sep 2021to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 5 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- age 2 and 5 years at the time of enrollment
- diagnosis of ASD confirmed by a study investigator who was experienced in ASD diagnosis.
Who cannot join
- a neurodevelopmental disorder of known etiology (e.g., fragile X syndrome)
- significant sensory or motor impairment,
- major physical problems such as a chronic serious health condition,
- seizures at time of entry. Children who developed seizures during the course of the study were not excluded.
- use of psychoactive medications,
- history of a serious head injury and/or neurologic disease,
- alcohol or drug exposure during the prenatal period,
- CARS-2 total score > 48 (severe ASD).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Mental Imagery Therapy for Autism (MITA) - a Randomized Controlled Study of Early Intervention Computerized Brain Training Program for Children With ASD
Mental Imagery Therapy for Autism (MITA) is a highly innovative adaptive language therapy application for children with autism. MITA exercises are limitless in variations, therefore avoiding routinization. Each activity is dynamic, quickly adjusting to the child's exact ability level. All activities are disguised as games that engage children. A 3-year observational clinical study of 6,454 children with ASD demonstrated that children who engaged with MITA showed 2.2-fold greater language improvement than children with similar initial evaluations (p<0.0001). This study explores MITA intervention in a randomized controlled trial of 60 children with ASD. Two- to five-year-old ASD children will be randomly assigned to one of two groups. The MITA group will supplement their conventional language therapy with MITA exercises. The control group will receive treatment-as-usual. The hypothesis is that the MITA group will show greater improvement in developmental milestones.
Read the detailed description
Among primates, humans have exceptionally long and widely distributed fronto-temporal and fronto-parietal tracts (such as the arcuate and superior longitudinal fasciculi), yet the maturation of these pathways depends on early experience. During childhood, these tracts are fine-tuned (largely via myelination and synaptogenesis) through engagement in syntactically rich conversations, imaginative pretend play, and narrative storytelling 5-9. Both biological factors-such as genetically shortened sensitive period for pathways development-and social factors-including limited conversational engagement, low syntactic complexity in daily interactions, lack of storytelling, and excessive passive screen time-can substantially reduce the functional development of these connections and profoundly alter a child's developmental trajectory.
Autistic individuals frequently face a compounding disadvantage from both biological and social factors during early development: a potentially abbreviated critical period, combined with reduced spontaneous engagement in reciprocal conversation, joint attention, and pretend play. These factors limit the experiential scaffolding that typically drives the maturation of fronto-parieto-temporal white-matter tracts.
In a subset of autistic adults these tracts remain structurally and functionally underdeveloped. This compromises the executive function of Prefrontal Synthesis (PFS): the deliberate, effortful co-activation and dynamic binding of distributed visuospatial representations in working memory in order to construct an integrated, manipulable "scene" or situation model. When PFS is impaired, individuals struggle to intentionally generate a unified visuospatial scene that simultaneously contains an agent (subject), an action, and a patient (object) in their correct spatial-temporal relations. Because most syntactic constructions (e.g., active vs. passive voice, relative clauses, prepositional phrases) evolved to efficiently encode precisely these visuospatial-relational configurations, PFS deficits can render sentence comprehension fragmentary or reliant on non-syntactic strategies (e.g., rote memorization or simple word-order heuristics). The autism community refers to this phenomenon as the lack of multi-cue responsivity, or stimulus overselectivity, or tunnel vision (since individuals focus on a single word rather than integrating multiple words within a sentence).
In the absence of robust compensatory mechanisms (which some autistic individuals do develop), this core deficit in constructing and manipulating internal situation models contributes to persistent difficulties with complex language comprehension, abstract reasoning, planning, and flexible adaptive behavior-often resulting in lifelong challenges with independent living for those at the more severely affected end of the spectrum.
About 20 years ago, investigators posed a critical question: if many autistic children show limited interest in conversations, imaginative play, and story listening, could structured, non-conversational exercises be developed that nonetheless train the same fronto-parieto-temporal networks underlying syntactic processing and mental scene construction? Moreover, could such brain training be delivered during the peak sensitive period for language and socio-cognitive development (ages 2-4 years)? To address this challenge, Mental Imagery Therapy for Autism (MITA), a tablet-based intervention was built around highly stylized, brightly colored animated characters that are frequently preferred by autistic children. MITA consists of adaptive, game-like exercises designed to systematically train PFS both within and outside the verbal domain.
Verbal exercises begin with basic receptive vocabulary and systematically progress to increasingly complex syntactic and relational structures, including noun-adjective coordination, spatial prepositions, agent-action-patient relations, and recursive embedding 30. For example, a child may be asked to "find the small red ball" or "put the cup behind the table." Vocabulary is deliberately constrained; the goal is not lexical expansion but rather the repeated practice of dynamically binding multiple features and objects into novel configurations using PFS.
Non-verbal exercises provide analogous PFS training through purely visual puzzles that require mental integration of dissociated parts into a unified whole, without any spoken instruction 31. For example, a child can be presented with two separate images of a train and a window pattern, and a choice of complete trains. The task is to find the correct complete train and to place it into the empty square. Difficulty scales by progressively increasing the number of features that must be simultaneously attended to and integrated (up to eight at the highest levels). Prior work has shown that many children who cannot yet follow explicit verbal instructions can nevertheless succeed on visually isomorphic non-verbal versions of the same integrative task 30.
Since its release in 2015, and without paid advertising, MITA has consistently ranked among the top language-therapy applications across major app stores (Apple App Store, Google Play Store, and Amazon App Store), accumulating more than 3 million downloads worldwide and indicating sustained parental interest. The app includes quarterly in-app parent-report assessments, yielding the largest longitudinal naturalistic dataset on the development of autistic children.
An observational analysis of this real-world longitudinal cohort (N = 6,454) found that children who engaged with MITA showed 2.2-fold greater gains on a composite parent-reported PFS outcome measure compared to age-, gender-, and severity-matched controls who did not engage with the app (p < 0.0001) 33.
These promising naturalistic (citizen-science) findings prompted the design and execution of a prospective randomized controlled trial (RCT) to establish causal efficacy under more rigorously controlled conditions. To minimize environmental and therapeutic confounders, a study was designed in which participants could be randomized and matched within the same clinical and educational setting. After contacting more than 300 specialized early-intervention centers across North America, South America, and Europe, only one institution-Somare Therapeutic and Educational Clinic in Foz do Iguaçu, Brazil- had both access to an appropriate pediatric population and the willingness to conduct an independent, investigator-initiated RCT at no cost to the research team. The clinic serves a homogeneous population of preschool-aged children with autism spectrum disorder (ASD) and provided an ideal setting for tight experimental control of concomitant interventions and daily routines.
Preschool children (aged 2-5 years) attending Somare Therapeutic and Educational Clinic with a confirmed diagnosis of ASD will be enrolled in the RCT after informed parental consent. Eligible participants will be pair-matched by age and CARS-2 total score, then randomized 1:1 to either an intervention group that received standard clinic-based early intervention plus daily MITA training for a minimum of 12 months, or active-control group, that received standard clinic-based early intervention plus an equivalent duration of computerized executive-function exercises (non-MITA). Both groups will continue to receive the clinic's usual intensive behavioral and speech-language interventions. An assessor blinded to group assignment will evaluate all participants every six months for 2.5 years using the Childhood Autism Rating Scale (CARS-2) as the outcome measure.
- Conditions
- ASD
- Being tested
- Mental Imagery Therapy for Autism (MITA), General executive function
- Keywords
- autism, intellectual disability, language, language acquisition, syntactic language, imagination, imagiration
- Medical subject headings
- Autistic Disorder, Intellectual Disability, Language
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mental Imagery Therapy for Autism (MITA)Behavioural
The treatment group received Prefrontal Synthesis (PFS)-training activities emphasizing mental-juxtaposition-of-objects organized into the gamified application MITA. MITA includes both verbal and nonverbal exercises aiming to develop voluntary imagination ability in general and PFS ability in particular. MITA verbal activities use higher forms of language, such as noun-adjective combinations, spatial prepositions, recursion, and syntax to train PFS: e.g., a child can be instructed to "put the large red dog behind the orange chair" or "identify the wet animal after the lion was showered by the monkey;" or "take animals home following an explanation that the lion lives above the monkey and under the cow". In every activity a child listens to a short story and then works within immersive interface to generate an answer. Correct answers are rewarded with pre-recorded encouragement.
General executive functionBehavioural
The active-control group received the same standard clinic-based early intervention but, during the tablet-computer-based therapy unit, used non-MITA applications targeting memory and executive functions (e.g., matching colors and shapes, logical sequences, same/different discrimination, sound discrimination, imitation and musicalization, early literacy and graphomotor skills, animal-sound matching, quantity-number association, comparison, counting, and introductory fractions).
| Study group | Role | What they receive |
|---|---|---|
| MITA-treatment | Experimental | The treatment group received PFS-training activities emphasizing mental-juxtaposition-of-objects organized into the gamified application MITA Receives: Behavioral: Mental Imagery Therapy for Autism (MITA) |
| Control | Active comparator | The active-control group received the same standard clinic-based early intervention but, during the tablet-computer-based therapy unit, used non-MITA applications targeting memory and executive functions (e.g., matching colors and shapes, logical sequences, same/different discrimination, sound discrimination, imitation and musicalization, early literacy and graphomotor skills, animal-sound matching, quantity-number association, comparison, counting, and introductory fractions). Receives: Behavioral: General executive function |
What is being measured
The primary outcome is the main question the study is designed to answer.
Childhood Autism Rating Scale (CARS-2)
The Childhood Autism Rating Scale, Second Edition (CARS-2) is a 15-item behavioral rating scale developed to quantitatively assess the severity of ASD. CARS-2 works by rating a child's behavior, characteristics, and abilities against the expected developmental growth of a typical child. Each item is scored from 1 to 4: 1 being normal for a child's age, 2 for mildly abnormal, 3 for moderately abnormal, and 4 as severely abnormal. CARS-2 score ranges from 15 (no pathology) to 60 (severe ASD) with 30 being the cutoff rate for a diagnosis of mild autism. Scores 30-37 indicate mild to moderate autism, while scores between 38 and 60 are characterized as severe autism 36.
Measured: the baseline, 6-months, 12-months, 18-months, 24-months, and 30-months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2026
- Study start1 Sep 2021
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ASDStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- ImagiRation, LLC
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07326423
- Sponsor's protocol ID
- 4924876
- Acronym
- MITA-RCT
- Status last verified
- Jan 2026
- First submitted
- 19 Dec 2025
- Last updated
- 8 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mental Imagery Therapy for Autism (MITA) - a Randomized Controlled Study of Early Intervention Computerized Brain Training Program for Children With ASD
- ClinicalTrials.gov ID
- NCT07326423
- Acronym / sponsor ID
- MITA-RCT / 4924876
- Conditions
- ASD
- Keywords
- autism, intellectual disability, language, language acquisition, syntactic language, imagination, imagiration
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- ImagiRation, LLCIndustry (pharma, biotech, devices)
- Study start
- 1 Sep 2021 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 8 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Mental Imagery Therapy for Autism (MITA) is a highly innovative adaptive language therapy application for children with autism. MITA exercises are limitless in variations, therefore avoiding routinization. Each activity is dynamic, quickly adjusting to the child's exact ability level. All activities are disguised as games that engage children. A 3-year observational clinical study of 6,454 children with ASD demonstrated that children who engaged with MITA showed 2.2-fold greater language improvement than children with similar initial evaluations (p<0.0001). This study explores MITA intervention in a randomized controlled trial of 60 children with ASD. Two- to five-year-old ASD children will be randomly assigned to one of two groups. The MITA group will supplement their conventional language therapy with MITA exercises. The control group will receive treatment-as-usual. The hypothesis is that the MITA group will show greater improvement in developmental milestones.
Detailed description
Among primates, humans have exceptionally long and widely distributed fronto-temporal and fronto-parietal tracts (such as the arcuate and superior longitudinal fasciculi), yet the maturation of these pathways depends on early experience. During childhood, these tracts are fine-tuned (largely via myelination and synaptogenesis) through engagement in syntactically rich conversations, imaginative pretend play, and narrative storytelling 5-9. Both biological factors-such as genetically shortened sensitive period for pathways development-and social factors-including limited conversational engagement, low syntactic complexity in daily interactions, lack of storytelling, and excessive passive screen time-can substantially reduce the functional development of these connections and profoundly alter a child's developmental trajectory.
Autistic individuals frequently face a compounding disadvantage from both biological and social factors during early development: a potentially abbreviated critical period, combined with reduced spontaneous engagement in reciprocal conversation, joint attention, and pretend play. These factors limit the experiential scaffolding that typically drives the maturation of fronto-parieto-temporal white-matter tracts.
In a subset of autistic adults these tracts remain structurally and functionally underdeveloped. This compromises the executive function of Prefrontal Synthesis (PFS): the deliberate, effortful co-activation and dynamic binding of distributed visuospatial representations in working memory in order to construct an integrated, manipulable "scene" or situation model. When PFS is impaired, individuals struggle to intentionally generate a unified visuospatial scene that simultaneously contains an agent (subject), an action, and a patient (object) in their correct spatial-temporal relations. Because most syntactic constructions (e.g., active vs. passive voice, relative clauses, prepositional phrases) evolved to efficiently encode precisely these visuospatial-relational configurations, PFS deficits can render sentence comprehension fragmentary or reliant on non-syntactic strategies (e.g., rote memorization or simple word-order heuristics). The autism community refers to this phenomenon as the lack of multi-cue responsivity, or stimulus overselectivity, or tunnel vision (since individuals focus on a single word rather than integrating multiple words within a sentence).
In the absence of robust compensatory mechanisms (which some autistic individuals do develop), this core deficit in constructing and manipulating internal situation models contributes to persistent difficulties with complex language comprehension, abstract reasoning, planning, and flexible adaptive behavior-often resulting in lifelong challenges with independent living for those at the more severely affected end of the spectrum.
About 20 years ago, investigators posed a critical question: if many autistic children show limited interest in conversations, imaginative play, and story listening, could structured, non-conversational exercises be developed that nonetheless train the same fronto-parieto-temporal networks underlying syntactic processing and mental scene construction? Moreover, could such brain training be delivered during the peak sensitive period for language and socio-cognitive development (ages 2-4 years)? To address this challenge, Mental Imagery Therapy for Autism (MITA), a tablet-based intervention was built around highly stylized, brightly colored animated characters that are frequently preferred by autistic children. MITA consists of adaptive, game-like exercises designed to systematically train PFS both within and outside the verbal domain.
Verbal exercises begin with basic receptive vocabulary and systematically progress to increasingly complex syntactic and relational structures, including noun-adjective coordination, spatial prepositions, agent-action-patient relations, and recursive embedding 30. For example, a child may be asked to "find the small red ball" or "put the cup behind the table." Vocabulary is deliberately constrained; the goal is not lexical expansion but rather the repeated practice of dynamically binding multiple features and objects into novel configurations using PFS.
Non-verbal exercises provide analogous PFS training through purely visual puzzles that require mental integration of dissociated parts into a unified whole, without any spoken instruction 31. For example, a child can be presented with two separate images of a train and a window pattern, and a choice of complete trains. The task is to find the correct complete train and to place it into the empty square. Difficulty scales by progressively increasing the number of features that must be simultaneously attended to and integrated (up to eight at the highest levels). Prior work has shown that many children who cannot yet follow explicit verbal instructions can nevertheless succeed on visually isomorphic non-verbal versions of the same integrative task 30.
Since its release in 2015, and without paid advertising, MITA has consistently ranked among the top language-therapy applications across major app stores (Apple App Store, Google Play Store, and Amazon App Store), accumulating more than 3 million downloads worldwide and indicating sustained parental interest. The app includes quarterly in-app parent-report assessments, yielding the largest longitudinal naturalistic dataset on the development of autistic children.
An observational analysis of this real-world longitudinal cohort (N = 6,454) found that children who engaged with MITA showed 2.2-fold greater gains on a composite parent-reported PFS outcome measure compared to age-, gender-, and severity-matched controls who did not engage with the app (p < 0.0001) 33.
These promising naturalistic (citizen-science) findings prompted the design and execution of a prospective randomized controlled trial (RCT) to establish causal efficacy under more rigorously controlled conditions. To minimize environmental and therapeutic confounders, a study was designed in which participants could be randomized and matched within the same clinical and educational setting. After contacting more than 300 specialized early-intervention centers across North America, South America, and Europe, only one institution-Somare Therapeutic and Educational Clinic in Foz do Iguaçu, Brazil- had both access to an appropriate pediatric population and the willingness to conduct an independent, investigator-initiated RCT at no cost to the research team. The clinic serves a homogeneous population of preschool-aged children with autism spectrum disorder (ASD) and provided an ideal setting for tight experimental control of concomitant interventions and daily routines.
Preschool children (aged 2-5 years) attending Somare Therapeutic and Educational Clinic with a confirmed diagnosis of ASD will be enrolled in the RCT after informed parental consent. Eligible participants will be pair-matched by age and CARS-2 total score, then randomized 1:1 to either an intervention group that received standard clinic-based early intervention plus daily MITA training for a minimum of 12 months, or active-control group, that received standard clinic-based early intervention plus an equivalent duration of computerized executive-function exercises (non-MITA). Both groups will continue to receive the clinic's usual intensive behavioral and speech-language interventions. An assessor blinded to group assignment will evaluate all participants every six months for 2.5 years using the Childhood Autism Rating Scale (CARS-2) as the outcome measure.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| MITA-treatment | Experimental | Behavioral: Mental Imagery Therapy for Autism (MITA)The treatment group received PFS-training activities emphasizing mental-juxtaposition-of-objects organized into the gamified application MITA |
| Control | Active comparator | Behavioral: General executive functionThe active-control group received the same standard clinic-based early intervention but, during the tablet-computer-based therapy unit, used non-MITA applications targeting memory and executive functions (e.g., matching colors and shapes, logical sequences, same/different discrimination, sound discrimination, imitation and musicalization, early literacy and graphomotor skills, animal-sound matching, quantity-number association, comparison, counting, and introductory fractions). |
Who may qualify
- Ages
- 2 to 5 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (2 listed)
- age 2 and 5 years at the time of enrollment
- diagnosis of ASD confirmed by a study investigator who was experienced in ASD diagnosis.
Key exclusion criteria (8 listed)
- a neurodevelopmental disorder of known etiology (e.g., fragile X syndrome)
- significant sensory or motor impairment,
- major physical problems such as a chronic serious health condition,
- seizures at time of entry. Children who developed seizures during the course of the study were not excluded.
- use of psychoactive medications,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mental Imagery Therapy for Autism (MITA)The treatment group received Prefrontal Synthesis (PFS)-training activities emphasizing mental-juxtaposition-of-objects organized into the gamified application MITA. MITA includes both verbal and nonverbal exercises aiming to develop voluntary imagination ability in general and PFS ability in particular. MITA verbal activities use higher forms of language, such as noun-adjective combinations, spatial prepositions, recursion, and syntax to train PFS: e.g., a child can be instructed to "put the large red dog behind the orange chair" or "identify the wet animal after the lion was showered by the monkey;" or "take animals home following an explanation that the lion lives above the monkey and under the cow". In every activity a child listens to a short story and then works within immersive interface to generate an answer. Correct answers are rewarded with pre-recorded encouragement. | Behavioural | MITA-treatment |
| General executive functionThe active-control group received the same standard clinic-based early intervention but, during the tablet-computer-based therapy unit, used non-MITA applications targeting memory and executive functions (e.g., matching colors and shapes, logical sequences, same/different discrimination, sound discrimination, imitation and musicalization, early literacy and graphomotor skills, animal-sound matching, quantity-number association, comparison, counting, and introductory fractions). | Behavioural | Control |
Primary outcome
Childhood Autism Rating Scale (CARS-2)
Time frame: the baseline, 6-months, 12-months, 18-months, 24-months, and 30-months
The Childhood Autism Rating Scale, Second Edition (CARS-2) is a 15-item behavioral rating scale developed to quantitatively assess the severity of ASD. CARS-2 works by rating a child's behavior, characteristics, and abilities against the expected developmental growth of a typical child. Each item is scored from 1 to 4: 1 being normal for a child's age, 2 for mildly abnormal, 3 for moderately abnormal, and 4 as severely abnormal. CARS-2 score ranges from 15 (no pathology) to 60 (severe ASD) with 30 being the cutoff rate for a diagnosis of mild autism. Scores 30-37 indicate mild to moderate autism, while scores between 38 and 60 are characterized as severe autism 36.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for ASD
Recruiting
Strategies for Toddler ASD With Remote-therapy (STAR) Model for ASD
Autism Spectrum Disorder, Therapy
Recruiting
Smith Magenis Syndrome and Autism Spectrum Disorders
Smith-Magenis Syndrome, Autism Spectrum Disorder
Active, not recruitingPhase 1
Psilocybin for Treatment-Resistant Depression in Autism
Treatment Resistant Depression, Autism Spectrum Disorder
RecruitingPhase 2
TRIal of PPF3 vs. PlaCEbo in the TReatment of Children and AdolescenTs With NeurOdeveloPmental DisorderS
Autism Disorder
Not yet recruitingObservational study
EEG As a Genetic Selection Lever in Autism Spectrum Disorder
Autism Spectrum Disorder (ASD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mental Imagery Therapy for Autism (MITA) and General executive function in people with ASD, run by ImagiRation, LLC at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 8 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Childhood Autism Rating Scale (CARS-2) (time frame: the baseline, 6-months, 12-months, 18-months, 24-months, and 30-months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2026.